| ■ 영문 제목 : Global Pediatric Drugs and Vaccines Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02138 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 114 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 소아용 의약품 및 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (디프테리아, 인플루엔자, 간염, 폐렴구균성 질환, 수막염균성 질환, 유행성 이하선염, 기타)와 용도별 시장규모 (신생아, 유아, 어린이) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 소아용 의약품 및 백신 시장 점유율 - 지역별 소아용 의약품 및 백신 시장규모 - 주요지역의 종류별 시장규모 (디프테리아, 인플루엔자, 간염, 폐렴구균성 질환, 수막염균성 질환, 유행성 이하선염, 기타) - 주요지역의 용도별 시장규모 (신생아, 유아, 어린이) - 미주의 소아용 의약품 및 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 소아용 의약품 및 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 소아용 의약품 및 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 소아용 의약품 및 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 소아용 의약품 및 백신 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA), Actelion Pharmaceuticals, AstraZeneca Plc. (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (USA), Allergan, - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Pediatric Drugs and Vaccines will have significant change from previous year. By the most conservative estimates of global Pediatric Drugs and Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 93410 million in 2020. Over the next five years the Pediatric Drugs and Vaccines market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 133690 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs and Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Newborn
Infant
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
1 Scope of the Report 2 Executive Summary 3 Global Pediatric Drugs and Vaccines by Company 4 Pediatric Drugs and Vaccines by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Pediatric Drugs and Vaccines Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Pediatric Drugs and Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Diphtheria Table 3. Major Players of Influenza Table 4. Major Players of Hepatitis Table 5. Major Players of Pneumococcal Diseases Table 6. Major Players of Meningococcal Diseases Table 7. Major Players of Mumps Table 8. Major Players of Others Table 9. Global Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg) Table 10. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) Table 11. Global Pediatric Drugs and Vaccines Revenue by Type (2016-2021) & ($ million) Table 12. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021) Table 13. Global Pediatric Drugs and Vaccines Sale Price by Type (2016-2021) Table 14. Global Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg) Table 15. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Table 16. Global Pediatric Drugs and Vaccines Value by Application (2016-2021) Table 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021) Table 18. Global Pediatric Drugs and Vaccines Sale Price by Application (2016-2021) Table 19. Global Pediatric Drugs and Vaccines Sales by Company (2019-2021) & (Kg) Table 20. Global Pediatric Drugs and Vaccines Sales Market Share by Company (2019-2021) Table 21. Global Pediatric Drugs and Vaccines Revenue by Company (2019-2021) ($ Millions) Table 22. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2019-2021) Table 23. Global Pediatric Drugs and Vaccines Sale Price by Company (2019-2021) Table 24. Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution and Sales Area Table 25. Players Pediatric Drugs and Vaccines Products Offered Table 26. Pediatric Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Pediatric Drugs and Vaccines Sales by Region (2016-2021) (Kg) Table 30. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021) Table 31. Global Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & ($ Millions) Table 32. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021) Table 33. Americas Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg) Table 34. Americas Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021) Table 35. Americas Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 36. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021) Table 37. Americas Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg) Table 38. Americas Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) Table 39. Americas Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg) Table 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Table 41. APAC Pediatric Drugs and Vaccines Sales by Region (2016-2021) & (Kg) Table 42. APAC Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021) Table 43. APAC Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & ($ Millions) Table 44. APAC Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021) Table 45. APAC Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg) Table 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) Table 47. APAC Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg) Table 48. APAC Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Table 49. Europe Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg) Table 50. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021) Table 51. Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 52. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021) Table 53. Europe Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg) Table 54. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) Table 55. Europe Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg) Table 56. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Table 57. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg) Table 58. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021) Table 59. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 60. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021) Table 61. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2016-2021) & (Kg) Table 62. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) Table 63. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2016-2021) & (Kg) Table 64. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Table 65. Key and Potential Regions of Pediatric Drugs and Vaccines Table 66. Key Application and Potential Industries of Pediatric Drugs and Vaccines Table 67. Key Challenges of Pediatric Drugs and Vaccines Table 68. Key Trends of Pediatric Drugs and Vaccines Table 69. Pediatric Drugs and Vaccines Distributors List Table 70. Pediatric Drugs and Vaccines Customer List Table 71. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026) & (Kg) Table 72. Global Pediatric Drugs and Vaccines Consumption Market Forecast by Region Table 73. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 75. Americas Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg) Table 76. Americas Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. APAC Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026) & (Kg) Table 78. APAC Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026) & ($ millions) Table 79. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg) Table 80. Europe Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions) Table 81. Middle East & Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) & (Kg) Table 82. Middle East & Africa Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) & ($ millions) Table 83. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026) & (Kg) Table 84. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2021-2026) Table 85. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions) Table 86. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2021-2026) Table 87. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026) & (Kg) Table 88. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2021-2026) Table 89. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions) Table 90. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2021-2026) Table 91. Merck & Co., Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 92. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 93. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 94. Merck & Co., Inc. (USA) Main Business Table 95. Merck & Co., Inc. (USA) Latest Developments Table 96. Abbott Laboratories (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 97. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered Table 98. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 99. Abbott Laboratories (USA) Main Business Table 100. Abbott Laboratories (USA) Latest Developments Table 101. Amgen, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 102. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 103. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 104. Amgen, Inc. (USA) Main Business Table 105. Amgen, Inc. (USA) Latest Developments Table 106. Eli Lilly and Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 107. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered Table 108. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 109. Eli Lilly and Company (USA) Main Business Table 110. Eli Lilly and Company (USA) Latest Developments Table 111. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 112. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered Table 113. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 114. F. Hoffmann-La Roche Ltd (Switzerland) Main Business Table 115. F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments Table 116. Genentech, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 117. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 118. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 119. Genentech, Inc. (USA) Main Business Table 120. Genentech, Inc. (USA) Latest Developments Table 121. GlaxoSmithKline plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 122. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered Table 123. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 124. GlaxoSmithKline plc. (UK) Main Business Table 125. GlaxoSmithKline plc. (UK) Latest Developments Table 126. Janssen Biologics B.V. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 127. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered Table 128. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 129. Janssen Biologics B.V. (USA) Main Business Table 130. Janssen Biologics B.V. (USA) Latest Developments Table 131. Actelion Pharmaceuticals Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 132. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered Table 133. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 134. Actelion Pharmaceuticals Main Business Table 135. Actelion Pharmaceuticals Latest Developments Table 136. AstraZeneca Plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 137. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered Table 138. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 139. AstraZeneca Plc. (UK) Main Business Table 140. AstraZeneca Plc. (UK) Latest Developments Table 141. Boehringer Ingelheim GmbH (Germany) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 142. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered Table 143. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 144. Boehringer Ingelheim GmbH (Germany) Main Business Table 145. Boehringer Ingelheim GmbH (Germany) Latest Developments Table 146. Bristol-Myers Squibb Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 147. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered Table 148. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 149. Bristol-Myers Squibb Company (USA) Main Business Table 150. Bristol-Myers Squibb Company (USA) Latest Developments Table 151. Allergan, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 152. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 153. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 154. Allergan, Inc. (USA) Main Business Table 155. Allergan, Inc. (USA) Latest Developments Table 156. Novartis AG (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 157. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered Table 158. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 159. Novartis AG (Switzerland) Main Business Table 160. Novartis AG (Switzerland) Latest Developments Table 161. Novo Nordisk A/S (Denmark) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 162. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered Table 163. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 164. Novo Nordisk A/S (Denmark) Main Business Table 165. Novo Nordisk A/S (Denmark) Latest Developments Table 166. Pfizer, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 167. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 168. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 169. Pfizer, Inc. (USA) Main Business Table 170. Pfizer, Inc. (USA) Latest Developments Table 171. Sanofi S.A (France) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 172. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered Table 173. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 174. Sanofi S.A (France) Main Business Table 175. Sanofi S.A (France) Latest Developments Table 176. Shionogi Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 177. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered Table 178. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 179. Shionogi Inc. (USA) Main Business Table 180. Shionogi Inc. (USA) Latest Developments Table 181. Takeda Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors Table 182. Takeda Pediatric Drugs and Vaccines Product Offered Table 183. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 184. Takeda Main Business Table 185. Takeda Latest Developments List of Figures Figure 1. Picture of Pediatric Drugs and Vaccines Figure 2. Pediatric Drugs and Vaccines Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pediatric Drugs and Vaccines Sales Growth Rate 2016-2026 (Kg) Figure 7. Global Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Pediatric Drugs and Vaccines Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Diphtheria Figure 10. Product Picture of Influenza Figure 11. Product Picture of Hepatitis Figure 12. Product Picture of Pneumococcal Diseases Figure 13. Product Picture of Meningococcal Diseases Figure 14. Product Picture of Mumps Figure 15. Product Picture of Others Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 Figure 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021) Figure 18. Pediatric Drugs and Vaccines Consumed in Newborn Figure 19. Global Pediatric Drugs and Vaccines Market: Newborn (2016-2021) & (Kg) Figure 20. Pediatric Drugs and Vaccines Consumed in Infant Figure 21. Global Pediatric Drugs and Vaccines Market: Infant (2016-2021) & (Kg) Figure 22. Pediatric Drugs and Vaccines Consumed in Child Figure 23. Global Pediatric Drugs and Vaccines Market: Child (2016-2021) & (Kg) Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2020 Figure 26. Pediatric Drugs and Vaccines Revenue Market by Company in 2020 ($ Million) Figure 27. Global Pediatric Drugs and Vaccines Revenue Market Share by Company in 2020 Figure 28. Global Pediatric Drugs and Vaccines Sales Market Share by Regions (2016-2021) Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in 2020 Figure 30. Americas Pediatric Drugs and Vaccines Sales 2016-2021 (Kg) Figure 31. Americas Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions) Figure 32. APAC Pediatric Drugs and Vaccines Sales 2016-2021 (Kg) Figure 33. APAC Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions) Figure 34. Europe Pediatric Drugs and Vaccines Sales 2016-2021 (Kg) Figure 35. Europe Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions) Figure 36. Middle East & Africa Pediatric Drugs and Vaccines Sales 2016-2021 (Kg) Figure 37. Middle East & Africa Pediatric Drugs and Vaccines Revenue 2016-2021 ($ Millions) Figure 38. Americas Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 39. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020 Figure 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 Figure 41. Americas Pediatric Drugs and Vaccines Sales Market Share by Application in 2020 Figure 42. United States Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 43. Canada Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 44. Mexico Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 45. Brazil Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Region in 2020 Figure 47. APAC Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2020 Figure 48. APAC Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 Figure 49. APAC Pediatric Drugs and Vaccines Sales Market Share by Application in 2020 Figure 50. China Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 51. Japan Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 52. Korea Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 53. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 54. India Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 55. Australia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 56. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 57. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020 Figure 58. Europe Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 Figure 59. Europe Pediatric Drugs and Vaccines Sales Market Share by Application in 2020 Figure 60. Germany Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 61. France Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 62. UK Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 63. Italy Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 64. Russia Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 65. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 66. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2020 Figure 67. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 Figure 68. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application in 2020 Figure 69. Egypt Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 70. South Africa Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 71. Israel Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 72. Turkey Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 73. GCC Country Pediatric Drugs and Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 74. Channels of Distribution Figure 75. Distributors Profiles |
| ※본 조사보고서 [세계의 소아용 의약품 및 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02138) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 소아용 의약품 및 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |